Coronavirus Notebook: Gilead Readies Remdesivir, China Expedites Clinical Approvals
Executive Summary
Gilead is ramping up preparations to scale up remdesivir production, as China’s Genetic Materials Management Office expedites approvals for antiviral drugs and vaccine studies in China.